These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 12450705)

  • 1. The Brighton Collaboration: addressing the need for standardized case definitions of adverse events following immunization (AEFI).
    Bonhoeffer J; Kohl K; Chen R; Duclos P; Heijbel H; Heininger U; Jefferson T; Loupi E
    Vaccine; 2002 Dec; 21(3-4):298-302. PubMed ID: 12450705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The development of standardized case definitions and guidelines for adverse events following immunization.
    Kohl KS; Gidudu J; Bonhoeffer J; Braun MM; Buettcher M; Chen RT; Drammeh B; Duclos P; Heijbel H; Heininger U; Hummelman E; Jefferson T; Keller-Stanislawski B; Loupi E; Marcy SM
    Vaccine; 2007 Aug; 25(31):5671-4. PubMed ID: 17400339
    [No Abstract]   [Full Text] [Related]  

  • 3. Can the Brighton Collaboration case definitions be used to improve the quality of Adverse Event Following Immunization (AEFI) reporting? Anaphylaxis as a case study.
    Gold MS; Gidudu J; Erlewyn-Lajeunesse M; Law B;
    Vaccine; 2010 Jun; 28(28):4487-98. PubMed ID: 20434547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Applicability, reliability, sensitivity, and specificity of six Brighton Collaboration standardized case definitions for adverse events following immunization.
    Kohl KS; Magnus M; Ball R; Halsey N; Shadomy S; Farley TA
    Vaccine; 2008 Nov; 26(50):6349-60. PubMed ID: 18805456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety reporting in developing country vaccine clinical trials-a systematic review.
    Muehlhans S; Richard G; Ali M; Codarini G; Elemuwa C; Khamesipour A; Maurer W; Mworozi E; Kochhar S; Rundblad G; Vuitton D; Rath B
    Vaccine; 2012 May; 30(22):3255-65. PubMed ID: 22406279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reporting of vaccine safety data in publications: systematic review.
    Bonhoeffer J; Zumbrunn B; Heininger U
    Pharmacoepidemiol Drug Saf; 2005 Feb; 14(2):101-6. PubMed ID: 15386705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccinovigilance in Europe--need for timeliness, standardization and resources.
    Lankinen KS; Pastila S; Kilpi T; Nohynek H; Mäkelä PH; Olin P
    Bull World Health Organ; 2004 Nov; 82(11):828-35. PubMed ID: 15640918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoimmune hepatitis: Brighton Collaboration case definition and guidelines for data collection, analysis, and presentation of immunisation safety data.
    Kochhar S; Assis DN; Mack C; Izurieta HS; Muratori L; Munoz A; Nordenberg D; Gidudu JF; Blau EF; Vierling JM
    Vaccine; 2024 Mar; 42(7):1812-1825. PubMed ID: 38368225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A systematic review of adverse events following immunization during pregnancy and the newborn period.
    Fulton TR; Narayanan D; Bonhoeffer J; Ortiz JR; Lambach P; Omer SB
    Vaccine; 2015 Nov; 33(47):6453-65. PubMed ID: 26413879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensorineural hearing loss (SNHL) as an adverse event following immunization (AEFI): Case definition & guidelines for data collection, analysis, and presentation of immunization safety data.
    Carol Liu YC; Ibekwe T; Kelso JM; Klein NP; Shehu N; Steuerwald W; Aneja S; Dudley MZ; Garry R; Munoz FM;
    Vaccine; 2020 Jun; 38(30):4717-4731. PubMed ID: 32418788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pediatric anaphylactic adverse events following immunization in Victoria, Australia from 2007 to 2013.
    Cheng DR; Perrett KP; Choo S; Danchin M; Buttery JP; Crawford NW
    Vaccine; 2015 Mar; 33(13):1602-7. PubMed ID: 25698493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding the role of human variation in vaccine adverse events: the Clinical Immunization Safety Assessment Network.
    LaRussa PS; Edwards KM; Dekker CL; Klein NP; Halsey NA; Marchant C; Baxter R; Engler RJ; Kissner J; Slade BA
    Pediatrics; 2011 May; 127 Suppl 1():S65-73. PubMed ID: 21502239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Key terms for the assessment of the safety of vaccines in pregnancy: Results of a global consultative process to initiate harmonization of adverse event definitions.
    Munoz FM; Eckert LO; Katz MA; Lambach P; Ortiz JR; Bauwens J; Bonhoeffer J
    Vaccine; 2015 Nov; 33(47):6441-52. PubMed ID: 26387433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse event following immunization (AEFI) surveillance in India, position paper of Indian Academy of Pediatrics,2013.
    Chitkara AJ; Thacker N; Vashishtha VM; Bansal CP; Gupta SG
    Indian Pediatr; 2013 Aug; 50(8):739-41. PubMed ID: 24036641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Awareness and utilization of reporting pathways for adverse events following immunization: online survey among pediatricians in Russia and Germany.
    Muehlhans S; von Kleist M; Gretchukha T; Terhardt M; Fegeler U; Maurer W; Namazova-Baranova L; Gaedicke G; Baranov A; Rath B
    Paediatr Drugs; 2014 Aug; 16(4):321-30. PubMed ID: 24849291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse events following immunization in Ontario's female school-based HPV program.
    Harris T; Williams DM; Fediurek J; Scott T; Deeks SL
    Vaccine; 2014 Feb; 32(9):1061-6. PubMed ID: 24440208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Encephalitis, myelitis, and acute disseminated encephalomyelitis (ADEM): case definitions and guidelines for collection, analysis, and presentation of immunization safety data.
    Sejvar JJ; Kohl KS; Bilynsky R; Blumberg D; Cvetkovich T; Galama J; Gidudu J; Katikaneni L; Khuri-Bulos N; Oleske J; Tapiainen T; Wiznitzer M;
    Vaccine; 2007 Aug; 25(31):5771-92. PubMed ID: 17570566
    [No Abstract]   [Full Text] [Related]  

  • 18. Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001.
    Zhou W; Pool V; Iskander JK; English-Bullard R; Ball R; Wise RP; Haber P; Pless RP; Mootrey G; Ellenberg SS; Braun MM; Chen RT
    MMWR Surveill Summ; 2003 Jan; 52(1):1-24. PubMed ID: 12825543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Applicability of the Brighton Collaboration Case Definition for seizure after immunization in active and passive surveillance in Canada.
    Top KA; Constantinescu CM; Laflèche J; Bettinger JA; Scheifele DW; Vaudry W; Halperin SA; Law BJ
    Vaccine; 2013 Nov; 31(48):5700-5. PubMed ID: 24099871
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.